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Abstract
Objective: To determine the prevalence of symptoms of asthma, rhinitis, and atopic eczema among schoolchildren
aged 6 to 7 years and adolescents aged 13 to 14 years in 20 Brazilian cities by using the standardized ISAAC written
questionnaire, and to assess the association of this prevalence with latitude, altitude and average annual temperature
of collaborating centers.
Methods: Schoolchildren and adolescents from five Brazilian regions participated in the study, totaling 23,422
ISAAC questionnaires answered by schoolchildrens parents and 58,144 questionnaires answered by adolescents. The
values for latitude, altitude and average annual temperature were obtained from the Brazilian Institute of Geography
and Statistics.
Results: The mean prevalence rates among schoolchildren and adolescents were respectively 24.3 and 19.0% for
active asthma; 12.6 and 14.6% for rhinoconjunctivitis; and 8.2 and 5.0% for atopic eczema. A significant negative
association was observed between latitude and physician-diagnosed asthma among schoolchildren, severe asthma,
physician-diagnosed asthma, eczema and atopic eczema among adolescents. No association with altitude was found.
Conclusions: The prevalence of asthma, rhinitis and atopic eczema in Brazil varies considerably. Higher prevalence
rates, especially of asthma and eczema, were found at centers located closer to the equator.
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Introduction
The International Study of Asthma and Allergies in
Childhood (ISAAC) was an important accomplishment for
epidemiological studies on the prevalence of asthma and
allergic diseases among children and adolescents. ISAAC
was designed to evaluate the prevalence of asthma and
allergic diseases among children and adolescents in different
regions of the world, using a standardized self-administered
written questionnaire and/or a video questionnaire.1,2
ISAAC self-administered written questionnaire (WQ) has
been the most widely used method, since it can be easily
applied, has a low cost, and does not require the presence
of a trained interviewer.1,2
The target population should include schoolchildren
within a specific geographic area (ISAAC center) aged 13
to 14 years and 6 to 7 years. The participation of
schoolchildren aged 6 to 7 years, albeit recommendable,
was not mandatory.
The study sample should include all children within the
selected age range from a random sample of schools.
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After determining the geographic area and the schools
that should be included, each center should choose
adolescents aged 13 to 14 years from the school database,
and apply the WQ. The selection of 6 to 7-year-olds should
follow the same criteria, and the parents of these children
would have to answer the WQ.
In ISAAC phase 1, a total of 463,801 adolescents (13
to 14 years old) from 155 centers in 56 countries (Europe,
Asia, Africa, North America, South America, and Oceania)
were interviewed, as well as 257,800 schoolchildren (6 to
7 years old) from 91 centers in 38 countries, from the
same continents, except `frica.2-5
The analysis of results at the end of phase 1 revealed
variable rates among schoolchildren and adolescents in
terms of the prevalence of wheezing in the last 12 months
(active asthma), between 4.1 and 32.1% for schoolchildren
and between 2.1 and 32.2% for adolescents.2,3 The
lowest rates were observed in the Republic of Georgia and
Estonia, whereas the highest rates were described in
Australia.2,3 In both age groups, Brazil ranked among the
countries with the highest prevalence rates.3,6
As to rhinitis, there was also a large variation in the
prevalence of related symptoms.4 The prevalence of nasal
symptoms in the absence of colds in the last year ranged
from 1.5 to 41.8% among schoolchildren and from 3.2 to
66.6% among adolescents.4 On the other hand, nasal
symptoms associated with eye symptoms (allergic
rhinoconjunctivitis) ranged from 0.8 to 14.9% among
schoolchildren and from 1.4 to 39.7% among adolescents.4
In general, the prevalence rates for asthma and rhinitis
were concordant: centers with a low asthma prevalence
(less than 5%: Indonesia, Albania, Romania, Georgia and
Greece) showed a low rhinitis prevalence, and those with
a high asthma prevalence (greater than 30%: Australia,
New Zealand, and the United Kingdom) also showed a high
rhinitis prevalence.3,4
The results for atopic eczema (AE) varied more widely
(up to 60 times), ranging between 0.3 and 20.5%.2,5 The
highest rates (greater than 15%) were observed in urban
centers in Africa, Australia, Northern and Western Europe,
whereas the lowest ones (less than 5%) were found in
China, Eastern Europe and Central Asia.2,5
Based on these data, several other studies were
carried out to assess the relationship between the
prevalence of asthma and of allergic diseases and possible
risk factors. Routine immunization,7 tuberculosis
notifications8,9 and nutritional status10 were some of the
analyzed factors. In a recent study, Weiland et al. assessed
the possible relationship between latitude, relative humidity
and annual variation of temperature of ISAAC centers
included in phase 1 and the prevalence of asthma and of
allergic diseases.11 They found a negative relationship
between these parameters and the prevalence of asthma
symptoms. On the other hand, the prevalence of eczema
symptoms was positively related to latitude and negatively
related to average temperature, i.e., places with smaller
temperature variations were associated with higher
prevalence rates.11 In conclusion, these authors assert
that climate plays an important role and can interfere in
the prevalence of asthma and AE.11
In Latin America, at the end of ISAAC phase 1, Mallol
et al. described a significant relationship between asthma
prevalence and severity and the latitude of participating
centers,12 some of which were Brazilian.
The small number of Brazilian centers in phase 1,
combined with the absence of centers in some Brazilian
regions, did not allow for such a study.6,13,14  The present
study aimed to assess the relationship between the
prevalence of symptoms of asthma, rhinitis, and eczema
and the latitude of different official ISAAC phase 3 Brazilian
centers and others that have only applied the ISAAC
protocol.
Patients and methods
Twenty-one centers in 20 Brazilian cities participated
in this study. The students were selected as recommended
by the ISAAC protocol.1,15 Each center, after determination
of the geographic area where the study should be carried
out, requested the Municipal Department of Education a
list of schools located in that area. After that, the schools
were randomly selected (random number table). The
following cities, states, and regions were included in the
study: Manaus, Amazonas, North (N); BelØm, ParÆ, N;
Natal, Rio Grande do Norte, Northeast (NE); Recife,
Pernambuco, NE; Caruaru, Pernambuco, NE; Maceió,
Alagoas, NE; Aracaju, Sergipe, NE; Feira de Santana,
Bahia, NE; Salvador, Bahia, NE; Vitória da Conquista,
Bahia, NE; Brasília, Distrito Federal, Midwest (MW); Belo
Horizonte, Minas Gerais, Southeast (SE); Nova Iguaçu,
Rio de Janeiro, SE; Sªo Paulo (West and South), Sªo
Paulo, SE; Santo AndrØ, Sªo Paulo, SE; Curitiba, ParanÆ,
South (S); Itajaí, Santa Catarina, S; Passo Fundo, Rio
Grande do Sul, S; Porto Alegre, Rio Grande do Sul, S;
Santa Maria, Rio Grande do Sul, S. Some of these centers
had their data approved by the ISAAC International Data
Center and were considered as ISAAC phase 3 official
centers (Tables 1 and 2). The study was approved by the
respective local Research Ethics Committees, and all
participants signed an informed consent form prior to the
interviews.
The following cities did not assess 6 to 7-year-olds (not
mandatory): BelØm, Recife, Caruaru, Brasília, Belo
Horizonte, Curitiba, Passo Fundo, Porto Alegre and Santa
Maria.
The study began in 2002 and finished in 2003, as
recommended by ISAAC, using the same dates for data
collection, whenever possible, in all centers. In the southern
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Center South Altitude Avg n Active Severe PD Rhini- Rhino- Severe Ecz** Atopic Severe
latitude m temp asthma* asthma asthma tis§ conjƒ rhinitis¶ ecz ecz
Manaus §§ 3.06 92 32 3,011 24.4 6.6 20.8 19.5 10.6 13.2 12.0 8.0 4.7
North  total 3,011 24.4 6.6 20.8 19.5 10.6 13.2 12.0 8.0 4.7
Natal 5.47 30 28 855 29.0 7.8 16.1 23.3 13.3 20.8 13.1 13.0 8.5
Maceió §§ 9.39 16 25 1,990 24.3 7.4 9.6 24.7 11.3 14.3 10.6 7.6 4.7
Aracaju §§ 10.54 4 25 2,443 16.5 4.5 11.3 19.9 10.3 16.3 13.0 11.4 9.1
Feira de Santana 12.16 235 24.1 440 20.7 5.2 6.4 35.9 15.5 24.3 7.3 8.2 7.3
Salvador §§ 12.58 8 24 998 17.2 3.0 7.7 39.8 17.4 26.0 8.6 7.3 5.7
Vitória da Conquista 14.51 923 20 399 24.3 8.5 11.5 31.3 17.3 21.8 10.5 8.3 7.8
Northeast  total 7,125 21.0 5.8 10.6 26.1 12.7 18.5 11.2 8.2 6.4
Nova Iguaçu §§ 22.45 25 21.8 3,249 26.3 7.0 10.4 24.8 12.2 16.6 13.3 9.8 6.0
Sªo Paulo  West §§ 23.30 760 20 3,312 31.2 8.4 7.1 28.9 15.1 19.7 12.4 9.5 5.2
Sªo Paulo  South §§ 23.32 760 20 3,047 24.4 4.8 6.3 28.2 12.7 17.6 11.0 7.3 3.2
Santo AndrØ §§ 23.39 755 23 2,167 23.9 2.9 4.9 30.9 13.2 16.5 8.1 5.3 2.1
Southeast  total 11,775 26.7 6.0 7.3 27.9 13.3 17.7 11.6 8.3 4.4
Itajaí §§ 26.54 1 21 1,511 20.6 6.8 10.3 19.3 13.3 14.5 10.7 8.7 3.4
South  total 1,511 20.6 6.8 10.3 19.3 13.3 14.5 10.7 8.7 3.4
Overall total 23,422 24.3 6.1 10.3 25.7 12.6 17.1 11.5 8.2 5.0
Table 1 - Prevalence of symptoms of asthma, rhinitis and atopic eczema among children (aged 6 to7 years) in different Brazilian centers
 International Study of Asthma and Allergies in Childhood (ISAAC) - Phase 3
Avg temp = average temperature; n = number of participants PD asthma = physician-diagnosed asthma; rhinoconj = rhinoconjunctivitis; ecz = eczema
* Wheezing in the last 12 months.
† Physician-diagnosed asthma: wheezing severe enough to limit speech to only two words at a time in the last 12 months.
‡ Asthma ever.
§ Sneezing, runny, or blocked nose at any time in the last 12 months.
¦ Rhinoconjunctivitis: nose problem accompanied by itchy-watery eyes in the last 12 months.
¶ Rhinitis interfering with daily activities.
** Eczema: itchy rash which was coming and going in the last 12 months.
†† Atopic eczema: skin rash at characteristic sites (skinfolds, etc.).
‡‡ Severe eczema: itchy rash causing sleep disturbance in the last 12 months.
§§ ISAAC phase 3 official center.
region, where the seasons of the year are more clearly
defined, the study was carried out before springtime in
order to avoid possible seasonal influences.
After definition of the sample, the ISAAC WQ, which
had been previously translated into Brazilian Portuguese
and validated,14,16,17 was answered by the parents of
schoolchildren aged 6 to 7 years (n = 23,422) and by
adolescents (n = 58,144, aged 13 to 14 years). The data
were manually transferred to the database provided by
ISAAC coordinators.
In the asthma module, there were questions about
symptoms, severity and diagnosis of asthma, such as:
wheezing in the last 12 months (active asthma); wheezing
severe enough to limit speech in the last 12 months
(severe asthma); asthma ever (physician-diagnosed
asthma).1,3
In the rhinitis module, there were questions about
rhinitis symptoms, allergic rhinoconjunctivitis and severe
forms of rhinitis: sneezing, runny nose, and blocked nose
at any time in the last 12 months (rhinitis); nose problems
accompanied by itchy-watery eyes in the last 12 months
(allergic rhinoconjunctivitis); nose problem interfering
with daily activities (severe rhinitis).1,4
The questions about eczema referred to its symptoms
and severity: skin rash which was coming and going in the
last 12 months (eczema); skin rash at characteristic sites
(atopic eczema); itchy rash causing sleep disturbance in
the past 12 months (severe eczema).1,5
The data about latitude, altitude and average annual
temperature for each of the participating centers were
obtained from the Brazilian Institute of Geography and
Statistics.18
The following non-parametric tests were used for data
analysis: Spearmans rank correlation coefficient (RS) and
the 95% confidence interval (95%CI). The significant
level was set at 5% for all tests.
Results
Among schoolchildren, the mean prevalence rates
were: 24.3% for active asthma, with higher rates in Sªo
Paulo  West and in Vitória da Conquista; 6.1% for
severe asthma, with higher rates in Sªo Paulo  West
and in Natal; 10.3% for physician-diagnosed asthma
(Manaus and Natal); 25.7% for rhinitis (Bahia, Feira de
Santana, Salvador and Vitória da Conquista); 12.6% for
rhinoconjunctivitis (Bahia); 17.1% for severe rhinitis
(Bahia); 11.5% for eczema, (Nova Iguaçu, Natal and
Aracaju); 8.2% for atopic eczema (Natal, Aracaju and
Nova Iguaçu); and 5.0% for severe eczema (Natal and
Aracaju) (Table 1).
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Table 2 - Prevalence of symptoms of asthma, rhinitis and atopic eczema among adolescents (aged 13 to 14 years) in different Brazilian
centers  International Study of Asthma and Allergies in Childhood (ISAAC) - Phase 3
Avg temp = average temperature; n = number of participants PD asthma = physician-diagnosed asthma; rhinoconj = rhinoconjunctivitis; ecz = eczema
* Wheezing in the last 12 months.
† Physician-diagnosed asthma: wheezing severe enough to limit speech to only two words at a time in the last 12 months.
‡ Asthma ever.
§ Sneezing, runny, or blocked nose at any time in the last 12 months.
¦ Rhinoconjunctivitis: nose problem accompanied by itchy-watery eyes in the last 12 months.
¶ Rhinitis interfering with daily activities.
** Eczema: itchy rash which was coming and going in the last 12 months.
†† Atopic eczema: skin rash at characteristic sites (skinfolds, etc.).
‡‡ Severe eczema: itchy rash causing sleep disturbance in the last 12 months.
§§ ISAAC phase 3 official center.
Center South Altitude Avg n Active Severe PD Rhini- Rhino- Severe Ecz** Atopic Severe
latitude m temp asthma* asthma asthma tis§ conjƒ rhinitis¶ ecz ecz
BelØm §§ 1.27 10 26 1,773 23.1 5.0 32.8 47.4 28.5 14.6 11.8 6.2 3.9
Manaus 3.06 92 32 3,009 18.1 5.8 19.7 23.0 12.8 14.6 10.7 5.8 5.0
North  total 4,782 19.9 5.5 24.6 32.0 18.6 14.6 11.1 6.0 4.6
Natal 5.47 30 28 1,020 18.9 5.2 16.2 32.0 20.0 23.8 9.6 7.2 5.8
Recife §§ 8.03 4 30 2,865 19.1 4.1 18.0 35.8 14.5 19.0 10.1 5.0 4.1
Caruaru §§ 8.17 555 26 3,026 17.9 5.0 19.7 25.5 15.4 17.5 10.3 6.5 6.1
Maceió §§ 9.39 16 25 2,745 14.8 5.0 13.8 26.4 13.8 15.3 7.5 4.0 3.3
Aracaju §§ 10.54 4 25 3,041 18.7 6.8 15.4 25.6 17.4 22.5 11.2 7.9 8.3
Feira de Santana §§ 12.16 235 24.1 1,732 21.5 6.2 5.8 33.0 17.2 25.3 8.5 5.8 6.6
Salvador §§ 12.58 8 24 3,020 24.6 5.9 13.7 44.2 24.4 28.2 10.7 6.5 6.1
Vitória da Conquista §§ 14.51 923 20 1,679 30.5 9.1 13.2 39.8 24.4 31.1 10.4 7.7 8.8
Northeast  total 19,128 20.3 5.8 14.5 32.4 13.3 17.9 9.9 6.2 6.0
Brasília §§ 15.46 1171 20.5 3,009 19.7 5.1 14.8 29.3 15.4 21.1 10.2 5.6 5.8
Mid-west  total 3,009 19.7 5.1 14.8 29.3 15.4 21.1 10.2 5.6 5.8
Belo Horizonte §§ 19.55 858 21 3,088 17.8 4.8 9.8 26.1 14.5 18.1 9.1 5.2 5.1
Nova Iguaçu §§ 22.45 25 21.8 3,185 11.8 3.3 7.3 17.4 8.9 10.1 9.0 4.1 3.3
Sªo Paulo - Oeste §§ 23.30 760 20 3,181 21.9 5.6 8.9 30.1 19.8 20.2 9.7 6.9 5.4
Sªo Paulo  Sul §§ 23.32 760 20 3,161 18.7 2.9 10.4 27.4 12.2 14.5 7.1 3.6 2.2
Santo AndrØ §§ 23.39 755 23 3,232 23.2 3.0 8.9 28.4 13.8 15.4 7.1 3.4 2.0
Southeast  total 15,847 18.7 3.9 9.1 25.9 13.8 15.7 8.4 4.6 3.6
Curitiba §§ 25.25 934 17 3,628 18.9 3.1 9.2 39.2 17.2 20.4 6.3 3.7 1.5
Itajaí §§ 26.54 1 21 2,737 12.3 2.6 11.1 22.1 12.9 14.7 7.0 4.0 3.9
Passo Fundo §§ 28.15 687 17.5 2,949 20.5 4.8 14.6 29.5 16.6 21.0 8.6 5.5 4.6
Porto Alegre §§ 28.15 10 20 3,007 18.2 4.8 21.2 32.1 15.9 20.0 7.0 5.0 5.0
Santa Maria 29.41 151 19.2 3,057 15.3 3.8 11.1 20.6 9.6 15.9 7.7 4.8 5.7
South  total 15,378 19.3 3.8 13.3 29.2 15.6 18.5 7.3 4.5 4.0
Overall total 58,144 19.0 4.7 13.6 29.6 14.6 17.4 8.9 5.0 4.4
Among adolescents, the mean prevalence rates were
as follows: 19.0% for active asthma, with higher rates
in Salvador and Vitória da Conquista; 4.7% for severe
asthma, with higher rates in Vitória da Conquista and
Aracaju; 13.6% for physician-diagnosed asthma (BelØm,
Porto Alegre and Caruaru); 29.6% for rhinitis (BelØm,
Salvador and Vitória da Conquista); 14.6% for allergic
rhinoconjunctivitis (BelØm, Salvador and Vitória da
Conquista); 17.4% for severe rhinitis (Bahia); 8.9% for
eczema (BelØm, Aracaju and Salvador); 5.0% for atopic
eczema (Aracaju, Vitória da Conquista and Natal); and
4.4% for severe eczema (Bahia and Aracaju) (Table 2).
The association between latitude and the prevalence of
symptoms and severity of asthma, rhinitis and AE showed
a negative statistical significance for physician-diagnosed
asthma (RS = -0.622; 95%CI -0.885 to -0.056; p = 0.031)
among schoolchildren, severe asthma (RS = -0.565;
95%CI -0.806 to -0.163; p = 0.008), physician-diagnosed
asthma (RS = -0.479; 95%CI -0.761 to -0.046; p = 0.028),
eczema (RS = -0.718; 95%CI -0.881 to -0.405;
p = 0.0002) and atopic eczema (RS = -0.530; 95%CI
-0.788 to -0.115; p = 0.013) among adolescents. In other
words, the smaller the latitude (close proximity to the
equator), the higher the prevalence of affirmative answers
to the questions.
With regard to the average annual temperature, there
was a positive association with physician-diagnosed asthma
(RS = 0.459; 95%CI 0.02 to 0.749; p = 0.037), and also
with eczema (RS = 0.541; 95%CI 0.129 to 0.794;
p = 0.011) among adolescents. Thus, the higher the
average annual temperature, the higher the prevalence of
physician-diagnosed asthma and eczema.
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Discussion
Higher prevalence rates for asthma and for allergic
diseases were observed in centers in the Northern and
Northeastern regions, except for the asthma prevalence,
which was also high in the Southern region. The threefold
increase in the number of assessed centers in comparison
to ISAAC phase 1,6,13,14 the inclusion of centers from all
Brazilian regions, and the high response rate2,3 allow us
to consider the sample to be representative of Brazil.
ISAAC phase 1 in Latin America collected data from 17
centers in nine countries and included 36,264 schoolchildren
and 52,549 adolescents. The prevalence of asthma and
associated symptoms was high and variable, as that which
has been described in industrialized countries or developed
regions.12 The prevalence of active asthma ranged from
8.6 to 32.1% among schoolchildren and from 6.6 to
27.0% among adolescents, and the highest prevalence
rates were observed in regions closest to the equator.
Moreover, no relationship was found between exposure to
environmental pollution, early exposure to respiratory
and gastrointestinal infections and asthma prevalence.12
These data cast some doubt on the validity of the Hygiene
Hypothesis for Latin America as a whole.12
Weiland et al. investigated the relationship between
climate (latitude, annual variation of temperature
(difference between maximum and minimum annual
temperatures) and indoor relative humidity) and the
prevalence of atopic diseases by using the data from
ISAAC phase 1 (146 centers). Asthma symptoms were
inversely related to altitude, variation of annual
temperatures and indoor relative humidity.11 The analysis
of some of these data showed that the prevalence of
asthma symptoms increased in western European countries
in association with the increase in the estimated annual
mean of indoor relative humidity.11 In the present study,
we observed a significant negative relationship to physician-
diagnosed asthma among schoolchildren and to physician-
diagnosed asthma and severe asthma among adolescents.
This may be explained by different approaches to and
different nomenclature of the disease across Brazil.
However, when we considered the prevalence of severe
forms, we found the same behavior among adolescents.
This certainly explains the higher asthma prevalence in
the Northern region. This is corroborated by the significant
positive association between the average annual
temperature and the prevalence of physician-diagnosed
asthma.
With regard to rhinitis and its associated symptoms,
we did not find a statistically significant association between
rhinitis prevalence and the analyzed parameters for both
age groups, as also observed in other studies.11
Nevertheless, there was a significant negative relationship
between the prevalence of eczema and of atopic eczema
and latitude. Higher rates were observed in Northern
Brazil, and the prevalence of eczema was higher in regions
with higher average temperatures. Exposure to higher
and constant temperatures, high level of environmental
humidity, greater exposure of the skin due to insufficient
clothing, combined with the higher frequency of skin
disorders in this region are some of the reasons for the
increase in the prevalence of eczema, a disorder that may
be characterized by different skin symptoms. However, the
exposure of patients with atopic eczema to the same
factors above does not increase the prevalence of this
disease. In this case, heat and humidity are considered
risk factors for AE. Differently from the findings of the
present study, Weiland et al. observed an increase in the
prevalence of eczema and related symptoms in both age
groups, with an increase in latitude and a decrease in the
variation of the average annual temperature, as well as
with an increase in indoor relative humidity.11
Nnoruka et al. assessed Nigerian children with AE and
found heat intolerance, excessive sweating, and indoor
humidity as aggravating factors for AE,19 similarly to what
has been described by other authors.20 FernÆndez-
Mayoralas et al. found out that air pollution had some
influence over the prevalence of AE among adolescents
who lived in Cartagena (Spain).21 The authors observed
high prevalence rates for AE and for severe forms of the
disease among those who were exposed to higher levels
of pollution.21 In the present study, we did not find any
influence of air pollution over the prevalence of AE,
especially when we consider Sªo Paulo and Santo AndrØ,
where the highest levels of air pollution in Brazil are
usually detected.
In conclusion, after the increase in the number of
centers participating in this study regarding ISAAC phase
1, and similarly to the results obtained for Latin America
at the end of phase 1, we found a higher frequency of
physician-diagnosed asthma among schoolchildren and
adolescents, and more severe forms of asthma, eczema
and atopic eczema among adolescents living close to the
equator. The identification of risk factors to which individuals
living in these centers may be exposed is a crucial step to
unravel the etiopathology of asthma and of allergic diseases
in these regions.
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